Search

Oxford Genome licenses a genomic database with a long pedigree to Belgium’s UCB

The official Irish government report on the failed Media Lab Europe project has focused attention another industry-academic research partnerships – one involving Bell Labs and a consortium of eight Irish universities.

Physicists in Bangalore have developed new uses for carbon nanotubes – as flow sensors. Now they are looking for more licensees to develop their work.

A novel procedure for the preparation of β-lactams, from non-natural substrates.

This device delivers large molecules directly into cells, and even into specific sites within cells, whilst avoiding the cellular damage associated with other drug delivery methods.

Steelmaker Arcelor, carmaker Daimler-Benz and some 50 companies are joining an effort by the French National Center for Scientific Research to form an education and research network to scout new metallic materials for industrial use.

Sigma-Aldrich, a US-based Nasdaq-listed life science company, has agreed to license a gene delivery technology from Oxford BioMedica and will pay $5 million for a stake in the spin out from Oxford University.

Michael Kenward's roundup of new studies, reports and tools for the business of science

Scientists love to complicate things; and if you're not in the same field, or – worse – are in business or investment, then it's easy to get lost. Enter the Science|Business Quick Guides to some of the hottest fields of science and technology…

Energy: The Manchester “bobber” is using the power of ocean waves to find a lower-cost route to alternative energy.

Partnerships: An EU project aims to design road-hardened microchips in a fast-changing market.

Imperial College London's technology commercialisation company is betting on a spin-out company, deltaDOT, to speed detection and decrease costs of finding new proteins for drug discovery.

Avidex is teaming up with diabetes specialists at King’s College London to work on a new approach to treating the Type I form of the disease.

Nuala’s Moran’s roundup of news and views in the management of intellectual assets Helpdesk

Europe looks increasingly likely to follow America’s lead and require drug companies to test their products in children. But Europe's pharma lack the resources to carry out drug trials in children — so industry and patients will have to rely on the skills developed in academic centres.

A new life-science fund said it raised €240.3 million – and promptly announced its first two investments.